Position in GSK
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$27,184,854
-$1,436,514 QoQ
Shares Held
518,597
0.0% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#60
of 1,032 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Welch & Forbes LLC holds $565,568,902 across 11 Drug Manufacturers - General names. GSK ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
172,704 | $207,146,375 | |
| 2 | JNJ |
Johnson & Johnson
|
657,989 | $167,109,466 | |
| 3 | ABBV |
AbbVie Inc.
|
345,978 | $87,061,903 | |
| 4 | MRK |
Merck & Co., Inc.
|
316,952 | $40,728,332 | |
| 5 | GSK |
GSK plc
This page
|
518,597 | $27,184,854 | |
| 6 | AMGN |
Amgen Inc
|
25,959 | $9,400,273 | |
| 7 | NVS |
Novartis AG
|
57,984 | $9,087,252 | |
| 8 | PFE |
Pfizer Inc
|
341,080 | $8,213,206 |
All Filings in GSK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,184,854 | 518,597 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $28,621,368 | 518,597 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $25,431,996 | 518,597 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $22,382,646 | 518,597 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $19,943,616 | 519,365 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $20,120,200 | 519,365 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $17,580,819 | 519,835 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $21,250,200 | 519,819 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $20,045,063 | 520,651 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $22,320,308 | 520,651 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $19,295,326 | 520,651 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $18,875,048 | 520,691 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $18,567,620 | 520,977 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $18,540,773 | 521,101 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $18,311,489 | 521,101 | Shares | Sole | 2023-02-02 | |
| 2022-06-30 | $27,810,120 | 651,379 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $27,829,287 | 651,379 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $28,174,278 | 651,379 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $24,411,319 | 651,379 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $25,439,903 | 651,379 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $22,815,362 | 651,779 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $23,535,846 | 652,081 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $24,073,077 | 652,081 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $26,100,737 | 652,407 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $24,245,082 | 652,407 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||